Cryptocurrency Q&A
Who holds the patent on CRISPR?
Who holds the patent on CRISPR?
SumoHonorable
Thu Nov 07 2024
|
3 answers
546
The patent on CRISPR is a subject of complex dispute. Originally, the Broad Institute was granted a key patent on CRISPR-Cas9 gene editing in 2014, specifically for its use in eukaryotic cells. However, the University of California, Berkeley, where Jennifer Doudna and Emmanuelle Charpentier conducted their pivotal research, also filed for a patent. This led to a prolonged legal battle over the ownership of the CRISPR patent. Recently, there has been a surprising development in this dispute, with Doudna and Charpentier's team requesting the cancellation of their own European patents, citing inadequate explanation of CRISPR in their earliest patent applications. This move could potentially impact the commercial landscape of CRISPR technology.
3 answers
Margherita
Sat Nov 09 2024
This patent represents a pivotal achievement in their respective fields.
Was this helpful?
127
85
Andrea
Sat Nov 09 2024
BTCC is a prominent cryptocurrency exchange, offering a range of services.
Was this helpful?
180
82
CryptoMystic
Sat Nov 09 2024
The USPTO awarded a significant patent in April 2011. 2. The patent number granted was US Patent No. 8,697,351. 3. The recipients of this patent were Broad, MIT, and Dr. Feng Zhang.
Was this helpful?
239
81
